| JYSB2000404 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | | Filed | 2020-09-01 | view |
| JXSS1000008 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2010-09-15 | | | Certificate Issued | 2012-08-28 | view |
| JYSZ1800033 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2018-07-20 | | Bayer Healthcare LLC | Certificate Issued | 2019-06-03 | view |
| JYSB2200092 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-09 | | | | | view |
| JXSL0800017 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2008-07-11 | Baxter AG | Baxter AG | Certificate Issued | 2010-03-15 | view |
| JYSB2400048 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-03-07 | | | | | view |
| JYSB1500126 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2015-05-08 | | | Certificate Issued | 2015-08-12 | view |
| JYSB1900354 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-01-01 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | In Review | 2019-12-31 | view |
| JXSL1600040 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2016-07-11 | | Bayer Healthcare LLC | Certificate Issued | 2018-07-27 | view |
| JYSB1400187 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2014-09-01 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2014-11-25 | view |
| JXSS1900049 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
| JYSB2000558 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-11-04 | | Bayer Healthcare LLC | Filed | 2020-11-17 | view |
| JYSZ1200014 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2012-04-05 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2014-06-06 | view |
| JYSB2200094 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-09 | | | | | view |
| JXSL0900029 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2009-05-11 | | Wyeth Pharmaceuticals Inc | Certificate Issued | 2010-05-27 | view |
| JYSB1500176 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2015-07-06 | | | Certificate Issued | 2015-12-25 | view |
| JYSB1400256 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2014-12-25 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2016-04-11 | view |
| JYSB2000596 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-12-14 | | | Certificate Issued | 2021-03-02 | view |
| JXSL1300052 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2013-07-30 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2014-11-25 | view |
| JXSS1000004 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2010-06-21 | | | Certificate Issued | 2012-05-10 | view |
